Journey Strategic Wealth’s Patterson-UTI PTEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PTEN
VPM
VCM
SG
Journey Strategic Wealth's PTEN Position: Q1 2026 in Review
Journey Strategic Wealth increased its Patterson-UTI (PTEN) stake by 4.3% in Q1 2026, buying an estimated $3.9K and bringing the position to 11,176 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #800.
Journey Strategic Wealth first reported a position in PTEN in Q4 2021 and has held it in 17 quarters since. The position peaked at $230K in Q1 2022. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.
- Journey Strategic Wealth held 11,176 shares of Patterson-UTI worth $121K as of Q1 2026.
- Journey Strategic Wealth bought 456 Patterson-UTI shares in Q1 2026, an estimated $3.9K.
- Patterson-UTI made up ﹤0.01% of Journey Strategic Wealth's portfolio in Q1 2026, its #800 holding.
- Journey Strategic Wealth first reported a position in Patterson-UTI in Q4 2021 and has held it in 17 quarters since.
- Journey Strategic Wealth's Patterson-UTI position peaked at $230K in Q1 2022.
- 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.
Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.